Capstone Quarterly Income Statement
NASDAQ: CAPSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Capstone revenue and earnings
In the quarter ended Sep 30, 2026, Capstone generated $20.0 million in revenue, up 46.2% from the same quarter a year earlier. Capstone reported a net loss of $632,000, compared with a loss of $2.0 million a year earlier. Gross margin was 28.7% (up from 23.8%) and operating margin 2.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Capstone income statement (quarterly)
| Quarter (USD) | Q3 20262026-09-30 | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q2 20192019-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19.96M | 21.48M | 12.64M | 12.48M | 13.65M | 12.85M | 7.90M | 10.31M | 12.32M | 12.89M | 9.36M | 0 |
| Revenue growth (YoY) | +46.15% | +67.13% | +59.97% | +20.97% | +10.85% | -0.26% | -15.60% | — | — | — | — | -100.00% |
| Cost of Revenue | 14.22M | 15.48M | 9.67M | 9.39M | 10.40M | 9.72M | 6.57M | 8.24M | 9.32M | 10.12M | 7.61M | — |
| Gross Profit | 5.74M | 6.00M | 2.97M | 3.08M | 3.25M | 3.13M | 1.32M | 2.07M | 2.99M | 2.76M | 1.75M | — |
| Operating Expenses | 5.33M | 5.57M | 4.47M | 11.61M | 4.02M | 3.39M | 2.75M | 2.42M | 2.58M | 2.75M | 2.46M | 605.00K |
| Research & Development | — | — | — | — | — | — | — | — | — | — | — | 339.00K |
| Selling, General & Admin | 5.24M | 5.51M | 4.47M | 4.86M | 3.37M | 3.39M | 2.75M | 2.42M | 2.58M | 2.75M | 2.46M | — |
| Operating Income | 406.00K | 432.00K | -1.50M | -8.53M | -768.00K | -260.00K | -1.43M | -348.00K | 413.00K | 14.00K | -717.00K | -605.00K |
| Interest Expense | 1.07M | 1.96M | 892.00K | 2.55M | 594.00K | 440.00K | 300.00K | 335.00K | 374.00K | 394.00K | 380.00K | — |
| Other Income (Expense) | 0 | 0 | 0 | — | 0 | 0 | 0 | — | 0 | 0 | — | -63.00K |
| Pretax Income | -631.00K | -1.38M | -1.91M | -9.61M | -2.01M | -700.00K | -1.73M | -683.00K | 39.00K | -380.00K | -1.10M | -668.00K |
| Income Tax | 1.00K | 3.00K | 2.00K | 7.18M | 0 | 0 | 0 | 420.00K | 5.00K | 1.00K | 16.00K | 0 |
| Net Income | -632.00K | -1.38M | -1.92M | -16.79M | -2.01M | -700.00K | -1.73M | -1.10M | 34.00K | -381.00K | -1.11M | -668.00K |
| Net Income growth (YoY) | — | — | — | — | -6023.53% | — | — | — | — | -199.74% | — | -152.27% |
| EPS (Basic) | -1.28 | -0.11 | -0.21 | 7.92 | -10.35 | -0.13 | -1.56 | -7.20 | -6.33 | -8.43 | -12.91 | -0.01 |
| EPS (Diluted) | — | — | — | — | -0.35 | -0.13 | -0.47 | -7.20 | -6.33 | -8.43 | -12.91 | -0.01 |
| Shares Outstanding (Basic) | 493.89K | 12.64M | 9.33M | — | 194.60K | 5.24M | 1.56M | — | 157.61K | 157.61K | 157.61K | 54.38K |
| Shares Outstanding (Diluted) | — | — | — | — | 5.70M | 5.41M | 5.19M | — | 157.61K | 157.61K | 157.61K | 54.38K |
| EBITDA | 548.00K | 595.00K | -1.34M | -8.49M | -650.00K | -146.00K | -1.31M | -404.00K | 538.00K | 135.00K | -597.00K | — |
| Gross Margin | 28.75% | 27.93% | 23.50% | 24.70% | 23.83% | 24.35% | 16.77% | 20.06% | 24.30% | 21.45% | 18.65% | — |
| Operating Margin | 2.03% | 2.01% | -11.85% | -68.37% | -5.62% | -2.02% | -18.08% | -3.37% | 3.35% | 11.00% | -7.66% | — |
| Net Margin | -3.17% | -6.42% | -15.16% | -134.56% | -14.75% | -5.45% | -21.88% | -10.70% | 28.00% | -2.96% | -11.89% | — |
This table shows 12 quarterly periods of Capstone's income statement, from Q3 2026 back to Q2 2019, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow CAPS's reporting calendar. What is a income statement?